Table 1

Clinical characteristics of the study population

Characteristics
DMa (n = 225)
CRIb (n = 196)
P

Gender (M/F)
76/149
65/131
0.89d
Age (years)
60.6 ± 11.5
57 ± 12.8
0.10c
BMI (kg/m2)
23.1 ± 0.3
23.4 ± 0.2
0.00
Duration of Diabetes (years)
17.07 ± 6.69
10.4 ± 7.7
<0.05c
Hb A1c (%)
7.3 ± 1.0
7.5 ± 1.1
0.949c
Systolic pressure (mm Hg) *
140 (106–190)
150 (110–210)
0.002e
Diastolic pressure (mm Hg) *
84 (80–104)
90 (70–110)
0.025e
Serum creatinine (μmol/l) *
84 (35–108)
177 (124–1112)
<<0.05e
UAER (mg/liter)*
10 (1–16)
864 (320–1584)
<<0.05e
GFR (mls/min/1.73 m2)
81.44 ± 21.85
27.83 ± 24
<<0.05c
Serum triglyceride (mmol/l)
1.7 ± 0.67
1.8 ± 1.4
0.307c
Serum cholesterol (mmol/l)
4.8 ± 0.97
4.9 ± 0.92
0.852c
Retinopathy (%) Non-proliferative (%) Proliferative (%)
24 15 09
88 35 53
<<0.05d
Cardiovascular events (%)
3
8.3


Data presented as mean ± SD (* median and range). atype-2 diabetes subjects without nephropathy (DM); b with diabetic renal insufficiency (CRI); c Student's t test; d Pearson's χ2 test; e Mann-Whitney U test.

Prasad et al. BMC Genetics 2008 9:26   doi:10.1186/1471-2156-9-26